BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

VWAP .272, no stock appreciates in a straight line and IMO this...

  1. 1,400 Posts.
    lightbulb Created with Sketch. 560
    VWAP .272, no stock appreciates in a straight line and IMO this is not the end of the current re-rate.
    If someone was to show me a NASDAQ listed biotech stock with the most advanced products pipeline in the world for the theraupetic applications of a particular molecule - which happens to be a molecule with one of the most exciting potential for applications of the last 50 years (!) - and I'd find out that this stock had -as for today - a MC of $138m USD, I 'd be rushing it to buy it. But the chances of that happening in the USA are slim, they'd know exactly how much a biotech like that would be worth.
    It's the usual 'cringe de fringe' that dogs any good Australian story.
    Last edited by aburbe: 10/07/19
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.